We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$9.27B
AUM Growth
+$916M
Cap. Flow
-$3.89M
Cap. Flow %
-0.04%
Top 10 Hldgs %
35.73%
Holding
278
New
28
Increased
73
Reduced
150
Closed
24

Top Buys

Rank Stock Value
1
GAP
The Gap Inc
GAP
+$73.5M
2
ROKU icon
Roku
ROKU
+$44.7M
3
AFRM icon
Affirm
AFRM
+$40.4M
4
OSCR icon
Oscar Health
OSCR
+$34.6M
5
GKOS icon
Glaukos
GKOS
+$23M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Consumer Discretionary 21.49%
3 Communication Services 15.02%
4 Healthcare 14.51%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
226
Vertex Pharmaceuticals
VRTX
$131B
$687K 0.01%
1,707
-333
-16% -$154K
VKTX icon
227
Viking Therapeutics
VKTX
$3.57B
$671K 0.01%
+16,678
New +$951K
BKV
228
BKV Corp
BKV
$2.65B
$566K 0.01%
23,809
-1,192
-5% -$24.1K
CYTK icon
229
Cytokinetics
CYTK
$9.91B
$559K 0.01%
11,892
-1,663
-12% -$86.4K
SNAP icon
230
Snap
SNAP
$10.1B
$507K 0.01%
47,118
-45
-0.1% -$507
ICE icon
231
Intercontinental Exchange
ICE
$87.9B
$447K ﹤0.01%
+2,997
New +$475K
LSCC icon
232
Lattice Semiconductor
LSCC
$15.2B
$437K ﹤0.01%
7,708
+652
+9% +$35.8K
THRY icon
233
Thryv Holdings
THRY
$84.9M
$430K ﹤0.01%
+29,034
New +$458K
KTOS icon
234
Kratos Defense & Security Solutions
KTOS
$8.99B
$399K ﹤0.01%
15,112
+41
+0.3% +$1.05K
ACMR icon
235
ACM Research
ACMR
$4.69B
$397K ﹤0.01%
26,260
-15
-0.1% -$271
ENFN
236
DELISTED
Enfusion, Inc.
ENFN
$394K ﹤0.01%
38,233
-18,532
-33% -$179K
MIR icon
237
Mirion Technologies
MIR
$3.72B
$388K ﹤0.01%
+22,234
New +$345K
APLD icon
238
Applied Digital
APLD
$6.93B
$385K ﹤0.01%
50,407
-169,766
-77% -$1.41M
PHAT icon
239
Phathom Pharmaceuticals
PHAT
$688M
$338K ﹤0.01%
41,610
-1,581,273
-97% -$19.6M
L icon
240
Loews
L
$22.2B
$329K ﹤0.01%
3,884
+122
+3% +$10.1K
CPNG icon
241
Coupang
CPNG
$26.9B
$304K ﹤0.01%
13,826
-314,800
-96% -$7.73M
FINW icon
242
FinWise Bancorp
FINW
$181M
$304K ﹤0.01%
19,011
-7,000
-27% -$119K
IAUX
243
i-80 Gold Corp
IAUX
$1.45B
$275K ﹤0.01%
567,566
-68,581
-11% -$55.4K
ROOT icon
244
Root
ROOT
$835M
$272K ﹤0.01%
+3,752
New +$259K
NEWP
245
New Pacific Metals
NEWP
$1.08B
$272K ﹤0.01%
230,660
-73,731
-24% -$115K
XOM icon
246
ExxonMobil
XOM
$687B
$266K ﹤0.01%
2,475
-1
-0% -$117
TPR icon
247
Tapestry
TPR
$23.4B
$264K ﹤0.01%
+4,047
New +$221K
LNTH icon
248
Lantheus
LNTH
$6.56B
$211K ﹤0.01%
2,356
-377,423
-99% -$36.8M
PLGO
249
Pelagos Insurance Capital
PLGO
$2.06B
$199K ﹤0.01%
10,970
-35,000
-76% -$650K
AZUL
250
DELISTED
Azul
AZUL
$189K ﹤0.01%
113,405
-48,738
-30% -$127K

Similar funds

Gilder Gagnon Howe & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Gilder Gagnon Howe & Co held 278 positions worth $9.27B, up 11% from $8.36B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2024 filing shows 28 new, 73 increased, 150 reduced and 24 closed positions. Its largest new stake was Roivant Sciences: 1,162,986 shares worth $13.8M. The largest sale was Lantheus, an estimated $36.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Gilder Gagnon Howe & Co's largest Q4 2024 buy was Roivant Sciences: 1,162,986 shares worth $13.8M.
  • Gilder Gagnon Howe & Co added most to The Gap Inc in Q4 2024, an estimated $73.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2024 reduction was Lantheus, cutting an estimated $36.8M.
  • Gilder Gagnon Howe & Co fully exited Newmont in Q4 2024, selling an estimated $21.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $9.27B portfolio in Q4 2024.
  • Gilder Gagnon Howe & Co opened 28 new positions and closed 24 in Q4 2024.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $9.27B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2024, filed 14 Feb 2025.